| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| FESTI | 1 | 4 | - | ||
| ARION BANK | 1 | 1 | -1,43 % | ||
| BRIM | 1 | - | - | ||
| ALVOTECH | 1 | - | 0,00 % | ||
| AMAROQ | - | 5 | -7,81 % | ||
| JBT MAREL | - | 2 | +1,03 % | ||
| ICELANDAIR GROUP HF | - | - | - | ||
| HAGAR | - | - | - | ||
| SKAGI | - | - | - |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18:15 | Brim Financial partners with Manulife Bank on credit cards | 3 | The Paypers | ||
| 17:45 | Festi hf.: Financial results for Q3 2026 | 302 | GlobeNewswire (Europe) | Revenue growth and cost discipline amid challenging external conditions Q3 2026 Key Operating Results Sales of goods and services amounted to ISK 51,147 million, up 8.6% year-on-year.Margin from sales... ► Artikel lesen | |
| 17:35 | Arion Bank hf.: Q3 2026 results | 326 | GlobeNewswire (Europe) | Arion Bank's return on equity was 16.3% in the third quarter of 2026 and 15.1% for the first nine months of 2026. Investor meeting and webcast in English on 29 October at 9:30 CET (8:30 GMT).
Financial... ► Artikel lesen | |
| 12:06 | Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026 | 8 | GlobeNewswire (USA) | ||
| Di | Arion Bank hf.: Arion Bank reaches settlement with the Financial Supervisory Authority | 213 | GlobeNewswire (Europe) | Arion Bank has reached a settlement with the Financial Supervisory Authority of the Central Bank of Iceland (the FSA). The settlement follows a review initiated by the FSA in April 2024 concerning the... ► Artikel lesen | |
| Mo | Kvika banki hf.: Transaction in relation to a share buy-back programme | 7 | GlobeNewswire (USA) | ||
| Fr | H.C. Wainwright reiterates Buy on Oculis stock, $39 target on biomarker data | 8 | Investing.com | ||
| Fr | Icelandair Q3 2026 slides: record revenue, tough winter ahead | 9 | Investing.com | ||
| Do | Icelandair Group hf.: financial results Q3 2026 | 242 | GlobeNewswire (Europe) | Record revenue of USD 655.0 million, up 12% year-on-yearEBIT of USD 120.3 million, improving by USD 45.9 million year-on-year, with the EBIT margin rising to 18.4% from 12.7%Profitability improved despite... ► Artikel lesen | |
| Do | Oculis veröffentlicht Biomarker-Daten aus Phase-2-Studie bei Optikusneuritis | 8 | Investing.com Deutsch | ||
| Do | Oculis reports biomarker data from optic neuritis trial | 5 | Investing.com | ||
| Do | Oculis Holding AG: Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor's Neuroprotective Potential in Optic Neuritis | 5 | GlobeNewswire (USA) |